Bridging Science to Practice: How FDA Applies Dissemination and Implementation Science Frameworks to Support Tobacco
Emily McDonald1, Anh Nguyen Zarndt1, Merrybelle Guo1
1Center for Tobacco Products, U.S. Food and Drug Administration, Silver Spring, Maryland.
American Journal of Preventive Medicine
|June 3, 2026
Summary
Dissemination and implementation science frameworks enhance tobacco control programs. The U.S. Food and Drug Administration's Center for Tobacco Products uses these models to improve public health education and reduce tobacco use.
Area of Science:
- Dissemination and implementation science
- Public health
- Tobacco control
Background:
- The U.S. Food and Drug Administration's Center for Tobacco Products (CTP) utilizes research to inform public health programs aimed at reducing tobacco use.
- Research translation is crucial for CTP's regulatory framework to minimize the population-level impact of tobacco.
- Effective tobacco prevention and education programs are vital for public health.
Purpose of the Study:
- To describe how CTP applies dissemination and implementation science frameworks.
- To enhance the effectiveness of tobacco prevention and education initiatives.
- To ensure continuous feedback between research and practice for maximized public health impact.
Main Methods:
- Application of the RE-AIM framework to CTP's "The Real Cost" youth tobacco prevention campaign.
- Utilization of the Knowledge-to-Action Framework for CTP's dissemination science activities.
- Integration of these frameworks into public education programs.
Main Results:
- The RE-AIM framework was applied to "The Real Cost" campaign, demonstrating effectiveness in preventing youth tobacco initiation.
- The Knowledge-to-Action Framework guided knowledge creation and synthesis for diverse audiences.
- Framework integration facilitated ongoing research-practice feedback loops.
Conclusions:
- Dissemination and implementation science frameworks are integral to CTP's strategy for effective tobacco control.
- These frameworks enhance the impact of public education programs, maximizing population-level benefit.
- Continuous integration of science ensures programs remain evidence-based and impactful.
More Related Videos
09:25Methods to Evaluate Cytotoxicity and Immunosuppression of Combustible Tobacco Product Preparations
Published on: January 10, 2015
06:05The Participant-Reported Implementation Update and Score (PRIUS): A Novel Method for Capturing Implementation-Related Data Over Time
Published on: February 19, 2021
Related Concept Videos
01:27Bioavailability Enhancement: Drug Permeability Enhancement
After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt secretion,...
01:25Drug Regulation
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
01:13Bioequivalence studies: Biowaivers
In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
02:59Cancer Prevention
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...